Posted by Colin Rose on October 1, 2008
After spending tens of $billions in DTC ads and bribes to doctors to terrorize the world into believing that blood “bad cholesterol” is the cause of atherosclerosis, the most common fatal disease, and selling hundreds of $billions worth of Lipitor to lower it, Pfizer has admitted there is no truth to and no more profit to be made from the myth of “dyslipidemia” that Pfizer and other peddlers of statin drugs created. Its much hyped drug, torceptripib, touted as the next Lipitor, which did all the “right” things to blood cholesterol actually worsened atherosclerosis in the ILLUSTRATE trial. Finally, the proof was in that high blood “bad cholesterol” is only a symptom of an atherogenic lifestyle, not the cause of atherosclerosis. But it will take a generation or two for the cholesterol myth to disappear.
So now Pfizer is directing more of its research toward Type 2 diabetes, a disease directly related to obesity, which is directly related to the moral hazard effect created by the cholesterol myth (I can eat anything as long as my cholesterol is low). Very clever marketing! Create diseases, real or imagined, then sell high profit drugs to to “treat” numbers associated with them.
PFIZER REFOCUSES ITS STRATEGY
BY SHANNON PETTYPIECE Bloomberg News
01 Oct 2008
Pfizer Inc. will abandon early-stage research on heart drugs as part of a strategy to sharpen its focus on ailments such as cancer, Alzheimer’s disease and diabetes where the chances of a bigger profit are greatest. The New York-based company, the…read more…
Posted in atherosclerosis, cholesterol, coronary artery disease, diabetes, Type 2, drugs, obesity, statins | Tagged: cholesterol, diabetes, dyslipidemia, Pfizer, torcetrapib, Type 2 | Leave a Comment »
Posted by Colin Rose on July 26, 2008
Here is a classical example of “free” online CME (Continuing Medical Education) funded by drug dealers and given legitimacy by association with presumably ethical institutions, like “prestigious educational institutes”. Doctors have to accumulate CME credits to maintain their licenses, so they are obliged to look at this propaganda. It seems doctors don’t make enough to pay for their own continuing education and have to depend upon the drug dealers to keep them informed. Shed a tear.
How much is McGill paid to allow it’s logo on this propaganda? McGill is a publicly chartered and funded institution. One should be able to find out but good luck.
Both members of the “Planning Committee” are compromised by financial connection to one or more drug dealers.
David Fitchett is particularly notorious for multiple connection to drug dealers.
But Dr. Fitchett is labeled an “expert”. What has Dr. Fitchett ever done, any more than any other graduate of a medical school, to be considered and expert? I have no idea.
Dr. David Fitchett, Expert
Watch a medical terrorist in action. Take that “powerful” statin to reach “target”, get that muscle pain. If you don’t you will die.
We are advised that “…it is unlikely that lipid targets can be achieved in the absence of pharmacological therapy” and we are given references for these targets. Who sets these targets, anyway? You haven’t guessed by now? In Canada it’s the “Working Group“, all of whom have financial connections with multiple drug dealers and who are chosen to be the conduits of divine revelation by groups like the Canadian Cardiovascular Society that get most of its funding from drug dealers.
And those “resources”? Again, paid for by drug dealers.
So, what appears on the surface to be a scientifically legitimate educational exercise turns out to be propaganda funded by drug dealers at multiple levels. Drug dealers pay doctors and their organizations to promote “targets” for blood cholesterol, pay “prestigious” institutions for their approval, pay for the web sites, like mdbriefcase, for CME to promote measurement of blood cholesterol and drugs to lower it and doctors must read it to keep their qualifications. What a wonderful marketing machine! And it’s all legal. But what happened to medical professionalism?
Posted in cardiology, cholesterol, drugs, professionalism, statins | Tagged: cholesterol, cme, continuing medical education, david fitchett, drug dealer, dyslipidemia, high risk patient, mcgill university, MD BriefCase, mdbriefcase, medical terrorism, NCEP, pharmaceutical company, professionalism, propaganda, statins, working group | Leave a Comment »
Posted by Colin Rose on May 4, 2007
Here is a classic example of drug dealers influencing the prescribing habits of doctors. If you read this GWTG-CAD carefully you will find a litany of insinuations WITHOUT PROOF. The data presented here are only observational. There is no control group. What were the lipids of the population that didn’t have a heart attack? The main insinuation is that the only cause of atherosclerosis is “dyslipidemia” and if the whole population of the world achieved “ideal” lipid levels by taking enough statins to lower their LDL to less than 70 mg/DL and somehow managed to also get their HDL higher than 60 mg/DL, there would be no heart attacks. There is NO PROOF for this hypothesis. 21% of the heart attack patients were on statins before their heart attack but still had one!
Now, if you want to know how such stupidity gets into print and gets the backing of the AHA, just look at the disclosures which are in small print at the bottom left. Enough said.
Posted in cholesterol, coronary artery disease, drugs, professionalism, statins | Tagged: Abbot, ACS, acute coronary syndrome, AHA, American Heart Association, AstraZeneca, BMS, CAD, cholesterol, Christopher Cannon, disclosure, drugs, dyslipidemia, Gregg Fonarow, GSK, guideline, GWTG, heart attack, Johnson, lipids, Merck, Merck Shering Plough, Pfizer, Prakash Deedwania, sanofi-aventis, statins | Leave a Comment »